Actinium Pharmaceuticals Inc. (Delaware) (ATNM) Financial Statements (2024 and earlier)

Company Profile

Business Address 100 PARK AVE., 23RD FLOOR
NEW YORK, NY 10017
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments76,677108,91077,82963,5609,25413,673
Cash and cash equivalents76,677108,91077,82963,5609,25413,673
Restricted cash and investments  69839243948 
Prepaid expense 1,360749935860  
Other current assets 226     
Other undisclosed current assets 58559366786656
Total current assets:78,263110,94279,74964,92510,08814,330
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization30358140221
Operating lease, right-of-use asset2,2892,341241579807
Property, plant and equipment550604340312113119
Restricted cash and investments313302    
Other undisclosed noncurrent assets    441441441
Total noncurrent assets:3,1823,2506391,4721,583560
TOTAL ASSETS:81,445114,19280,38866,39711,67014,889
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:    4,3404,5985,814
Other undisclosed accounts payable and accrued liabilities    4,3404,5985,814
Debt7,96410,1345,59785746249
Other undisclosed current liabilities5304941,243342  
Total current liabilities:8,49410,6286,8404,7675,3446,063
Noncurrent Liabilities
Long-term debt and lease obligation19    13
Capital lease obligations13
Finance lease, liability19    
Liabilities, other than long-term debt36,553     
Deferred revenue35,000    
Operating lease, liability1,553    
Other undisclosed noncurrent liabilities  37,0833311682 
Total noncurrent liabilities:36,57237,083331168213
Total liabilities:45,06647,7116,8435,0786,0266,077
Equity
Equity, attributable to parent36,37966,48173,54561,3195,6448,813
Common stock28262218165116
Additional paid in capital373,934355,220329,271292,275214,237195,554
Accumulated deficit(337,583)(288,765)(255,748)(230,974)(208,758)(186,857)
Total equity:36,37966,48173,54561,3195,6448,813
TOTAL LIABILITIES AND EQUITY:81,445114,19280,38866,39711,67014,889

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues811,0301,144   
Sublease income  1,0301,144  
Other income 100     
Cost of revenue   (900)   
Gross profit: 811,030244   
Operating expenses(52,001)(35,134)(26,108)(22,393)(22,071)(23,827)
Other undisclosed operating income  900   
Operating loss:(51,920)(34,104)(24,964)(22,393)(22,071)(23,827)
Nonoperating income3,1021,087190178172173
Interest and debt expense (2)(9)   
Loss from continuing operations:(48,818)(33,019)(24,783)(22,215)(21,899)(23,654)
Loss before gain (loss) on sale of properties:(24,783)(22,215)(21,899)(23,654)
Other undisclosed net income   9   
Net loss:(48,818)(33,019)(24,774)(22,215)(21,899)(23,654)
Other undisclosed net income attributable to parent 2    
Net loss attributable to parent:(48,818)(33,017)(24,774)(22,215)(21,899)(23,654)
Other undisclosed net loss available to common stockholders, basic    (1)(1) 
Net loss available to common stockholders, diluted:(48,818)(33,017)(24,774)(22,216)(21,900)(23,654)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(48,818)(33,019)(24,774)(22,215)(21,899)(23,654)
Comprehensive loss, net of tax, attributable to parent:(48,818)(33,019)(24,774)(22,215)(21,899)(23,654)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: